Page 42 - GTM-2-2
P. 42

Global Translational Medicine                                           Gut microbiota in Onco-Hematology



               indoxyl  sulfate  levels  early  after transplantation  reflect   51.  Hanahan D, Weinberg RA, 2000, The hallmarks of cancer.
               a disrupted microbiome and are associated with poor   Cell, 100: 57–70.
               outcome. Blood, 126: 1723–1728.
                                                                  https://doi.org/10.1016/s0092-8674(00)81683-9
               https://doi.org/10.1182/blood-2015-04-638858
                                                               52.  Newman JV, Kosaka T, Sheppard BJ, et al., 2001, Bacterial
            41.  Jenq RR, Ubeda C, Taur Y,  et al., 2012, Regulation of   infection promotes colon tumorigenesis in Apc(Min/+)
               intestinal inflammation by microbiota following allogeneic   mice. J Infect Dis, 184: 227–230.
               bone marrow transplantation. J Exp Med, 209: 903–911.
                                                                  https://doi.org/10.1086/321998
               https://doi.org/10.1084/jem.20112408
                                                               53.  Wu S, Rhee KJ, Albesiano E, et al., 2009, A human colonic
            42.  Dubin K, Callahan MK, Ren B,  et al., 2016, Intestinal   commensal promotes colon tumorigenesis via activation of
               microbiome analyses identify melanoma patients at risk for   T helper Type 17 T cell responses. Nat Med, 15: 1016–1022.
               checkpoint-blockade-induced colitis. Nat Commun, 7: 10391.
                                                                  https://doi.org/10.1038/nm.2015
               https://doi.org/10.1038/ncomms10391
                                                               54.  Diwan BA, Ward JM, Ramljak D, et al., 1997, Promotion by
            43.  Chaput N, Lepage P, Coutzac C,  et  al., 2017, Baseline   Helicobacter hepaticus-induced hepatitis of hepatic tumors
               gut microbiota predicts clinical response and colitis in   initiated by N-nitrosodimethylamine in male A/JCr mice.
               metastatic melanoma patients treated with ipilimumab. Ann   Toxicol Pathol, 25: 597–605.
               Oncol, 28: 1368–1379.
                                                                  https://doi.org/10.1177/019262339702500610
               https://doi.org/10.1093/annonc/mdx108
                                                               55.  Yamamoto ML, Maier I, Dang AT,  et al., 2013, Intestinal
            44.  Shen S, Lim G, You Z, et al., 2017, Gut microbiota is critical   bacteria modify lymphoma incidence and latency by
               for  the induction of  chemotherapy-induced  pain.  Nat   affecting systemic inflammatory state, oxidative stress, and
               Neurosci, 20: 1213–1216.                           leukocyte genotoxicity. Cancer Res, 73: 4222–4232.
               https://doi.org/10.1038/nn.4606                    https://doi.org/10.1158/0008-5472.can-13-0022

            45.  Wang Y, Wiesnoski DH, Helmink BA,  et al., 2018, Fecal   56.  Barlow C, Hirotsune S, Paylor R, et al., 1996, Atm-deficient
               microbiota  transplantation  for refractory immune   mice: A paradigm of ataxia telangiectasia. Cell, 86: 159–171.
               checkpoint  inhibitor-associated  colitis.  Nat  Med,
               24: 1804–1808.                                     https://doi.org/10.1016/s0092-8674(00)80086-0
               https://doi.org/10.1038/s41591-018-0238-9       57.  Reliene R, Schiestl RH, 2006, Antioxidant N-acetyl cysteine
                                                                  reduces incidence and multiplicity of lymphoma in Atm
            46.  Huang Y, Yang W, Liu H, et al., 2012, Effect of high-dose   deficient mice. DNA Repair (Amst), 5: 852–859.
               methotrexate chemotherapy on intestinal  Bifidobacteria,
               Lactobacillus and  Escherichia coli in children with acute      https://doi.org/10.1016/j.dnarep.2006.05.003
               lymphoblastic leukemia.  Exp Biol Med (Maywood),   58.  Reliene R, Schiestl RH, 2006, Differences in animal housing
               237: 305–311.                                      facilities and diet may affect study outcomes-a plea for
               https://doi.org/10.1258/ebm.2011.011297            inclusion of such information in publications. DNA Repair
                                                                  (Amst), 5: 651–653.
            47.  Montassier E, Gastinne T, Vangay P,  et al., 2015,
               Chemotherapy-driven  dysbiosis  in  the  intestinal     https://doi.org/10.1016/j.dnarep.2006.02.001
               microbiome. Aliment Pharmacol Ther, 42: 515–528.   59.  Fujiwara D, Wei B, Presley LL, et al., 2008, Systemic control
               https://doi.org/10.1111/apt.13302                  of plasmacytoid dendritic cells by CD8+ T cells and
                                                                  commensal microbiota. J Immunol, 180: 5843–5852.
            48.  Scully C, Epstein J, Sonis S, 2003, Oral mucositis:
               A challenging complication of radiotherapy, chemotherapy,      https://doi.org/10.4049/jimmunol.180.9.5843
               and  radiochemotherapy:  Part  1,  pathogenesis  and   60.  West NR, Powrie F, 2015, Immunotherapy not working?
               prophylaxis of mucositis. Head Neck, 25: 1057–1070.   Check your microbiota. Cancer Cell, 28: 687–689.
               https://doi.org/10.1002/hed.10318                  https://doi.org/10.1016/j.ccell.2015.11.010
            49.  Iida N, Dzutsev A, Stewart CA,  et al., 2013, Commensal   61.  Arpaia N, 2013, Metabolites produced by commensal
               bacteria control cancer response to therapy by modulating   bacteria promote peripheral regulatory T-cell generation.
               the tumor microenvironment. Science, 342: 967–970.   Nature, 504: 451–455.
               https://doi.org/10.1126/science.1240527            https://doi.org/10.1038/nature12726
            50.  Matutes E, 2007, Adult T-cell leukaemia/lymphoma. J Clin   62.  Vetizou M, Pitt JM, Daillere R,  et al., 2015, Anticancer
               Pathol, 60: 1373–1377.
                                                                  immunotherapy by CTLA-4 blockade relies on the gut
               https://doi.org/10.1136/jcp.2007.052456            microbiota. Science, 350: 1079–1084.


            Volume 2 Issue 2 (2023)                         12                       https://doi.org/10.36922/gtm.0389
   37   38   39   40   41   42   43   44   45   46   47